You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Glioma includes ependymoma and medulloblastoma

Showing 1 - 25 of 7,698
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

CNS Tumors, Atypical Teratoid/Rhabdoid Tumor, Diffuse Midline Glioma, H3 K27M-Mutant Trial in Memphis (B7-H3-CAR T cells)

Not yet recruiting
  • Central Nervous System Neoplasms
  • +6 more
  • B7-H3-CAR T cells
  • Memphis, Tennessee
    St. Jude Children's Research Hospital
Apr 18, 2023

Medulloblastoma, Glioblastoma Multiforme, Anaplastic Astrocytoma Trial in Buffalo, New York, Cincinnati (SurVaxM for patients

Recruiting
  • Medulloblastoma
  • +7 more
  • SurVaxM for patients with relapsed or progressive MB, HGG or ependymoma ages ≥10 and ≤21 years
  • +2 more
  • Buffalo, New York
  • +2 more
Jul 8, 2022

Radiation Therapy in Pediatric Central Nervous System Tumors

Completed
  • Diffuse Intrinsic Pontine Glioma
  • +4 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 26, 2023

    Glioblastoma, Medulloblastoma, Ependymoma Trial in Augusta, Druid Hills, Boston (Indoximod, Partial Radiation, Full-dose

    Recruiting
    • Glioblastoma
    • +3 more
    • Augusta, Georgia
    • +2 more
    Aug 18, 2022

    CNS Tumor, Diffuse Intrinsic Pontine Glioma, Diffuse Midline Glioma Trial in Seattle (SCRI-CARB7H3(s); B7H3-specific chimeric

    Recruiting
    • Central Nervous System Tumor
    • +10 more
    • SCRI-CARB7H3(s); B7H3-specific chimeric antigen receptor (CAR) T cel
    • Seattle, Washington
      Seattle Children's Hospital
    Dec 14, 2022

    Medulloblastoma, CNS Tumor, Pediatric, Ependymoma Trial in Beijing

    Recruiting
    • Medulloblastoma
    • +5 more
      • Beijing, Beijing, China
        Beijing Tiantan Hosiptal
      Jan 3, 2023

      Testing Cerebrospinal Fluid for Cell-free Tumor DNA in Children,

      Not yet recruiting
      • Anaplastic Astrocytoma
      • +17 more
        • (no location specified)
        Jun 28, 2023

        CNS Tumor, Pediatric, Glioma, Ependymoma Trial in Seattle (EGFR806-specific chimeric antigen receptor (CAR) T cell)

        Active, not recruiting
        • Central Nervous System Tumor, Pediatric
        • +8 more
        • EGFR806-specific chimeric antigen receptor (CAR) T cell
        • Seattle, Washington
          Seattle Children's Hospital
        Jan 18, 2023

        High Grade Glioma, Meningioma, Embryonal Tumor Trial in United States (LUTATHERA® (Lutetium Lu 177 dotatate))

        Recruiting
        • High Grade Glioma
        • +12 more
        • LUTATHERA® (Lutetium Lu 177 dotatate)
        • Aurora, Colorado
        • +8 more
        Jan 16, 2023

        CNS Tumor, Pediatric, Glioma, Ependymoma Trial in Seattle (HER2-specific chimeric antigen receptor (CAR) T cell)

        Recruiting
        • Central Nervous System Tumor, Pediatric
        • +8 more
        • HER2-specific chimeric antigen receptor (CAR) T cell
        • Seattle, Washington
          Seattle Children's Hospital
        Dec 14, 2022

        Anaplastic Ependymoma, Atypical Teratoid/Rhabdoid Tumor, CNS Germ Cell Tumor Trial in Houston (drug, procedure, biological)

        Recruiting
        • Anaplastic Ependymoma
        • +14 more
        • Houston, Texas
          M D Anderson Cancer Center
        Aug 17, 2022

        Ependymoma, Ewing Sarcoma, High-grade Glioma Trial in Worldwide (Nivolumab, NKTR-214)

        Completed
        • Ependymoma
        • +9 more
        • Nivolumab
        • NKTR-214
        • Little Rock, Arkansas
        • +17 more
        Dec 8, 2022

        CNS Tumors, Glioblastoma, Gliosarcoma, Adult Trial run by the (ONC206)

        Recruiting
        • Central Nervous System Neoplasms
        • +22 more
        • Bethesda, Maryland
          National Institutes of Health
        Mar 1, 2022

        CNS Tumors, Medulloblastoma Trial in Worldwide (Pomalidomide)

        Active, not recruiting
        Has Results
        • Central Nervous System Neoplasms
        • Medulloblastoma
        • Stanford, California
        • +24 more
        Sep 28, 2022

        Malignant Glioma, Ependymoma Trial in United States (Optune System (NovoTTF-200A System, Tumor Treating Fields, TTFields))

        Active, not recruiting
        • Malignant Glioma
        • +2 more
        • Optune System (NovoTTF-200A System, Tumor Treating Fields, TTFields)
        • Concurrent Optune and RT followed by Optune System alone
        • Los Angeles, California
        • +8 more
        Jan 17, 2023

        CNS Sarcoma, Ependymoma, Glioma Trial in Houston (Placebo Administration, Questionnaire Administration, Wound Dressing Material)

        Withdrawn
        • Central Nervous System Sarcoma
        • +6 more
        • Placebo Administration
        • +2 more
        • Houston, Texas
          M D Anderson Cancer Center
        Nov 28, 2020

        Brain and CNS Tumors Trial in Australia, United States (Induction Chemotherapy, Low-Risk Therapy, High-Risk Therapy)

        Active, not recruiting
        Has Results
        • Brain and Central Nervous System Tumors
        • Induction Chemotherapy
        • +3 more
        • Palo Alto, California
        • +5 more
        Nov 29, 2022

        Glioblastoma Multiforme, Glioma, Gliosarcoma Trial in United States (Indoximod, Temozolomide, Conformal Radiation)

        Completed
        • Glioblastoma Multiforme
        • +7 more
        • Aurora, Colorado
        • +4 more
        Jun 3, 2020

        Advanced Malignant Solid Tumor, Recurrent Childhood Ependymoma, Recurrent Ewing Sarcoma Trial in Puerto Rico, United States

        Active, not recruiting
        • Advanced Malignant Solid Neoplasm
        • +31 more
        • Laboratory Biomarker Analysis
        • +2 more
        • Birmingham, Alabama
        • +118 more
        Jan 27, 2023

        Ewing's Sarcoma, Osteosarcoma, Astrocytoma Trial in Atlanta (sirolimus)

        Completed
        • Ewing's Sarcoma
        • +15 more
        • Atlanta, Georgia
          Children's Healthcare of Atlanta
        May 27, 2020

        Advanced Malignant Solid Tumor, Ann Arbor Stage III Childhood Non-Hodgkin Lymphoma, Ann Arbor Stage IV Childhood Non-Hodgkin

        Active, not recruiting
        • Advanced Malignant Solid Neoplasm
        • +35 more
        • Birmingham, Alabama
        • +113 more
        Jun 28, 2022

        Glioma, Neuroectodermal Tumors, Primitive, Wilms Tumor Trial in Saint Louis (Metronomic Cyclophosphamide, Thalidomide)

        Recruiting
        • Glioma
        • +6 more
        • Saint Louis, Missouri
          Washington University School of Medicine
        Sep 22, 2021

        Malignant Solid Tumor, Recurrent Ependymoma, Recurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor Trial in Puerto

        Recruiting
        • Malignant Solid Neoplasm
        • +26 more
        • Birmingham, Alabama
        • +121 more
        Aug 24, 2022

        Advanced Malignant Solid Tumor, Recurrent Ependymoma, Recurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor Trial

        Recruiting
        • Advanced Malignant Solid Neoplasm
        • +30 more
        • Larotrectinib Sulfate
        • Birmingham, Alabama
        • +123 more
        Aug 23, 2022

        Advanced Malignant Solid Tumor, Recurrent Ependymal Tumor, Recurrent Ewing Sarcoma Trial in Puerto Rico, United States

        Active, not recruiting
        • Advanced Malignant Solid Neoplasm
        • +35 more
        • Birmingham, Alabama
        • +108 more
        Oct 19, 2022